Results 21 to 30 of about 149,686 (307)

ON YELLOW FEVER. [PDF]

open access: yesThe Lancet, 1878
n ...
openaire   +2 more sources

The thermal stability of yellow fever vaccines

open access: yesMemorias do Instituto Oswaldo Cruz, 1990
The assessment of yellow fever vaccine thermostability both in lyophilized form and after reconstitution were analyzed. Two commercial yellow fever vaccines were assayed for their thermal stability. Vaccines were exposed to test temperatures in the range
Ricardo Ishak, Colin R. Howard
doaj   +1 more source

Landscape connectivity for yellow fever: a proxy approach to detect displacement and circulation through environmental corridors and interfaces

open access: yesThe Lancet Planetary Health, 2021
Background: Yellow fever is an arboviral haemorrhagic disease transmitted by mosquitoes in the tropical regions of Africa and South America. WHO estimates that there are 200 000 severe cases and 30 000 deaths worldwide annually. In Brazil, the wild cycle
André Luís Acosta, PhD   +4 more
doaj   +1 more source

Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India

open access: yesIndian Journal of Community and Family Medicine, 2017
Background: Prevention of Yellow Fever (YF) in travellers to Yellow Fever endemic zone can be done with YF 17D vaccine which is a live attenuated vaccine and can be given only up to one hour after reconstitution.
Dhananjay Kumar   +5 more
doaj   +1 more source

Anamnestic immune response to dengue and decreased severity of yellow fever

open access: yesJournal of Global Infectious Diseases, 2009
A protective immunity against yellow fever, from cross-reactive dengue antibodies, has been hypothesized as an explanation for the absence of yellow fever in Southern Asia where dengue immunity is almost universal.
Ricardo O Izurieta   +7 more
doaj   +1 more source

Descriptive Characterization of Suspected Yellow Fever Cases in Kano state, Nigeria, 2015-2018

open access: yesJournal of Interventional Epidemiology and Public Health, 2021
Introduction: Yellow fever remains a serious public health problem globally with an estimated 200, 000 cases annually despite the availability of an effective vaccine for more than 70 years. Nigeria had an outbreak of Yellow fever in 2017 after more than
Usman Yahya Umar   +4 more
doaj   +1 more source

PET Imaging of Cardiac Inflammation in Viral Myocarditis Using a DPP4‐Targeted Probe

open access: yesAdvanced Science, EarlyView.
This study describes a DPP4‐targeted PET probe for imaging myocardial inflammation by selectively targeting activated immune cells. Derived from the clinically approved small‐molecule inhibitor linagliptin, the probe demonstrates favorable biodistribution with specific cardiac uptake in myocarditis.
Wanhao Gao   +14 more
wiley   +1 more source

SERS Facemask for Rapid and Portable Sensing Mycobacterium Tuberculosis Antigens for TB Screening

open access: yesAdvanced Science, EarlyView.
Our study introduced an Au─Ag embedded covalent organic framework (U@COF) ‐mediated facemask for sensing TB antigen ESAT‐6/CFP‐10 complex in clinical droplet samples toward TB screening. Practical analysis of clinical samples demonstrated the availability of our facemask, which is capable of identifying the TB subjects (N = 17) from healthy candidates (
Lingzhi Chen   +20 more
wiley   +1 more source

Yellow Fever in Nigeria: A Review of Past, Current, and Future Strides

open access: yesThe Proceedings of the Nigerian Academy of Science, 2022
Since 1985, there has been resurgence of yellow fever in Africa with outbreaks occurring in more than 33 countries. From that time, thousands of cases have occurred in Nigeria which is the most populous country in Africa.
Anyebe B. Onoja   +5 more
doaj   +1 more source

p300 Degradation by the p53‐SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity

open access: yesAdvanced Science, EarlyView.
This study identifies p300 as the acetyltransferase that acetylates TBK1 and inhibits its phosphorylation. Activation of the p53‐SIAH1 axis by immune response downregulates p300 expression to sustain innate antiviral immunity. Conditional p300 knockout in alveolar epithelial cells in vivo promotes antiviral responses and suppresses virus replication ...
Huidi Yu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy